Regeneron Genetics Center has launched a large-scale proteomics research initiative involving nearly 200,000 patient samples from Geisinger, using Thermo Fisher's Olink Explore HT platform. This project aims to validate genetic findings, discover novel biomarkers, and accelerate drug development by integrating proteomic and genomic data. Its unprecedented scale and planned analyses promise to drive innovations in precision medicine and biomarker discovery.